PT Multi Indocitra Tbk (MICE) Fair Value & Analysis
Consumer Defensive · ID · Market cap 303B IDR
Fair value as of: Jul 16, 2026
From 12 valuation models · updated 25 days ago
Share price +4.0% over the past month.
Below-average quality, screening 135% undervalued on our models.
What matters now
- The price is below even our cautious bear case (926.80 IDR). The market is more pessimistic than our downside scenario.
- Solid quality (49/100) at a price below fair value, the discount is the argument here, not the business quality.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 16, 2026.
How to read this chart
60‑month range 255.56 IDR – 810.53 IDR · fair‑value band 926.80 IDR – 1,545 IDR · the 525.00 IDR price screens below the 1,236 IDR fair value. Dashed = 300-day average. As of Jul 16, 2026.
Analysis
PT Multi Indocitra Tbk (MICE) currently trades at 525.00 IDR, while our model-based Fair Value estimate is 1,236 IDR, implying the stock looks roughly 135.4% undervalued today. The Quality Score stands at 49/100 (below-average quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, PT Multi Indocitra Tbk generated revenue of 1.3T IDR at a net margin of 3.1%. Revenue grew 35.4% year over year. It earns a return on equity of 4.3%. Net debt stands at 241B IDR. Fundamentals as of Jul 16, 2026
Our scenario range runs from 926.80 IDR (bear case) to 1,545 IDR (bull case); at 525.00 IDR, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 35% below its 52-week high and 21% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -26% fair-value upside, at 135%, MICE screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 12 models by family
Widest divergence: DCF Models (2,260 IDR) versus Dividend Discount (169.70 IDR). Highest evidence: Residual Income (76).
Notify me when MICE reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 16, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 48 · Market factors (momentum, volatility) 48
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
PT Multi Indocitra Tbk produces and distributes baby and health care products, and cosmetics in Indonesia. The company offers baby products and mother care products, such as bottle teats, pacifiers, breast pumps, baby toiletries, diapers, wet wipes, and toys, as well as products for senior citizens under the Pigeon brand. It also provides logistics services.
Full company description
PT Multi Indocitra Tbk produces and distributes baby and health care products, and cosmetics in Indonesia. The company offers baby products and mother care products, such as bottle teats, pacifiers, breast pumps, baby toiletries, diapers, wet wipes, and toys, as well as products for senior citizens under the Pigeon brand. It also provides logistics services. The company was founded in 1990 and is based in Jakarta Barat, Indonesia.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
PT Multi Indocitra Tbk reported revenue of 1.2T IDR in FY2025 versus 771B IDR in FY2021, a compound +11.9%/yr. Reported net income was 43.6B IDR in FY2025, compounding +9.7%/yr from FY2021.
of which total revenue +8.0 pp · buybacks/dilution +0.1 pp
Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).
Watch MICE: get an alert when its fair value changes →
Peer Group
Household & Personal Products · 244 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Household & Personal Products median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jul 16, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| The Procter & Gamble Company PG | $146.80 | $108.16 | -26% |
| Unilever PLC ULN | 1,080 MXN | 1,273 MXN | +18% |
| Hindustan Unilever Limited HINDUNILVR | ₹2,144 | ₹1,000 | -53% |
| Essity AB ESSITYA | kr 279.00 | kr 250.02 | -10% |
| Godrej Consumer Products Limited GODREJCP | ₹1,088 | ₹367.64 | -66% |
| Marico Limited MARICO | ₹846.75 | ₹233.05 | -72% |
| APR Co 278470 | 375,000 KRW | 151,222 KRW | -60% |
| Dabur India Limited DABUR | ₹429.45 | ₹181.60 | -58% |
| Kimberly-Clark de México, S. A. B. de C. V., KIMBERA | 38.07 MXN | 50.09 MXN | +32% |
| PT Unilever Indonesia Tbk UNVR | 1,730 IDR | 1,934 IDR | +12% |
Compare PT Multi Indocitra Tbk with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is PT Multi Indocitra Tbk (MICE) overvalued or undervalued?
What is the fair value of MICE?
What is the quality score of MICE?
What is the revenue of PT Multi Indocitra Tbk (MICE)?
What is the net profit margin of MICE?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track PT Multi Indocitra Tbk and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.